BIOVIE INC
For the period ended Jun 30, 2024. Filed Sep 30, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Sep 30, 2024
BIVI$1.30-2.3%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Balance Sheets
| June 30, | June 30, | |
|---|---|---|
| 2024 | 2023 | |
| ASSETS | ||
| CURRENT ASSETS: | ||
| Cash and cash equivalents | $23,843,798 | $19,460,883 |
| Investments in U.S. Treasury Bills (available-for-sale) | - | 14,477,726 |
| Prepaid and other current assets | 204,392 | 102,526 |
| Total current assets | 24,048,190 | 34,041,135 |
| Operating lease right-of-use assets, net | 406,726 | 80,789 |
| Intangible assets, net | 407,718 | 637,095 |
| Goodwill | 345,711 | 345,711 |
| TOTAL ASSETS | $25,208,345 | $35,104,730 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| CURRENT LIABILITIES: | ||
| Accounts payable and accrued expenses | $3,586,912 | $3,476,259 |
| Other current liabilities | - | 48,385 |
| Current portion of operating lease liabilities | 60,343 | 44,909 |
| Current portion of note payable, net of financing cost, unearned premium and discount of $701,210 at June 30, 2024 and $894,926 at June 30, 2023 | 5,701,210 | 9,105,074 |
| Warrant liability | 3,771 | 894,280 |
| Embedded derivative liability | - | 925,762 |
| Total current liabilities | 9,352,236 | 14,494,669 |
| Operating lease liabilities, net of current portion | 349,894 | 42,505 |
| Note payable, net of current portion, financing cost, unearned premium and discount of $0 and $227,268 at June 30, 2024 and June 30, 2023, respectively. | - | 5,227,270 |
| TOTAL LIABILITIES | 9,702,130 | 19,764,444 |
| Commitments and contingencies (Note 11) | ||
| STOCKHOLDERS' EQUITY : | ||
| Preferred stock; $0.001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding | - | - |
| Common stock, $0.0001 par value; 800,000,000 shares authorized at June 30, 2024 and June 30, 2023, respectively; 6,216,398 shares issued of which 6,190,072 shares are outstanding at June 30, 2024; and 3,645,183 shares issued of which 3,642,895 shares outstanding at June 30, 2023 | 6,229 | 3,643 |
| Additional paid in capital | 349,732,674 | 316,385,759 |
| Accumulated other comprehensive income | - | 176,591 |
| Accumulated deficit | (334,232,661) | (301,225,705) |
| Treasury stock | (27) | (2) |
| Total stockholders' equity | 15,506,215 | 15,340,286 |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $25,208,345 | $35,104,730 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.